The global anti-pollution nasal spray market size was valued at USD 7.94 billion in 2024 and is anticipated to reach USD 10.91 billion by 2030, growing at a CAGR of 5.51% from 2025 to 2030. This growth is primarily attributed to escalating air pollution levels worldwide, which continue to rise due to rapid industrialization, increasing urban population density, and the surge in vehicular emissions. These factors collectively intensify environmental pollution, thereby fueling higher demand for nasal sprays designed to protect against airborne contaminants.

As harmful pollutants—including PM2.5, PM10, nitrogen dioxide (NO2), sulfur dioxide (SO2), and ozone (O3)—continue to accumulate in the atmosphere, they contribute substantially to nasal irritation, inflammation, and overall respiratory discomfort. Such pollutants aggravate sensitive nasal tissues and heighten the risk of respiratory disorders. Consequently, there has been a noticeable rise in conditions such as allergic rhinitis, sinusitis, and asthma, prompting individuals to adopt preventive solutions like anti-pollution nasal sprays to reduce exposure and safeguard their respiratory health.

According to the European Environment Agency, pollution levels recorded in 2021 significantly exceeded the thresholds recommended by the World Health Organization (WHO) air quality guidelines. Had these recommended levels been met, a considerable number of pollution-related fatalities across EU Member States (EU-27) could have been avoided. This includes an estimated 253,000 deaths linked to exposure to fine particulate matter (PM2.5) and 52,000 deaths attributed to nitrogen dioxide (NO2) exposure. Furthermore, lowering short-term exposure to ozone (O3) could have prevented an additional 22,000 deaths, underscoring the severity of air quality concerns in the region.

Similarly, insights from the report titled Integrated Assessment of Air Pollution and Climate Change for Sustainable Development in Africa, published by the Climate and Clean Air Coalition (CCAC), the African Union Commission, and the United Nations Environment Programme (UNEP), highlight a comparable public health crisis in Africa. According to the Assessment, if African nations implement the recommended measures aimed at reducing air pollution while addressing climate change, they could potentially prevent 200,000 premature deaths each year by 2030. Moreover, by continuing these interventions, the number of preventable deaths could rise to 880,000 annually, illustrating the urgent need for pollution-control strategies to protect public health.

Key Market Trends & Insights:

• The North America anti-pollution nasal spray market emerged as the leading regional market, holding a dominant share of 38.54% in 2024. This strong position reflects the region’s heightened awareness of respiratory health, increased exposure to pollution sources such as vehicular emissions and industrial activities, and widespread adoption of preventive healthcare solutions. Additionally, higher consumer spending power and the presence of established healthcare infrastructure contribute to North America’s substantial market share.

• Within North America, the U.S. accounted for 74.85% of the regional market in 2024, demonstrating its significant influence on the overall market dynamics. The large share is driven by factors such as the country’s high pollution-prone urban areas, growing concerns about airborne allergens, and rising demand for over-the-counter protective nasal products. The strong presence of key market players and continuous product innovations further strengthen the U.S. market position.

• In terms of product segmentation, the pollution defense products segment captured the largest revenue share of 28.54% in 2024. This segment includes specialized formulations designed to shield nasal passages from particulate matter, allergens, and harmful gases. The dominance of this category indicates increasing consumer preference for daily-use protective products that help reduce pollutant intake and support long-term respiratory wellness.

• Regarding distribution channels, retail pharmacies held the largest revenue share of 32.87% in 2024. Retail pharmacies remain the most accessible and trusted outlets for consumers seeking nasal sprays, offering convenience, product variety, and professional guidance. Their widespread presence across urban and suburban areas has made them a preferred purchasing point, contributing to their strong share in the market.

Order a free sample PDF of the Anti-pollution Nasal Spray Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 7.94 Billion

• 2030 Projected Market Size: USD 10.91 Billion

• CAGR (2025-2030): 5.51%

• North America: Largest market in 2024

Key Companies & Market Share Insights:

Leading companies in the IVIG market include Haleon plc, GSK plc, Merck & Co., Inc., and Himalaya Wellness Company. These established players continue to strengthen their market presence by investing heavily in research and development, expanding their manufacturing capacities, and broadening their global footprint. Such efforts are aimed at effectively meeting the rising demand for nasal spray products, ensuring consistent supply, and supporting product advancements that cater to evolving consumer and clinical needs.

Product innovation and regulatory approvals remain essential strategic pillars for these companies as they work to maintain a competitive advantage within the IVIG market. Leading industry participants prioritize the development of advanced formulations and the expansion of their therapeutic product portfolios, focusing on solutions that can deliver improved efficacy, safety, and patient convenience. Securing approvals from relevant regulatory bodies further enables these organizations to strengthen their market reach and accelerate product commercialization.

At the same time, emerging companies in the IVIG landscape are concentrating on niche segments, particularly those involving novel delivery mechanisms and innovative therapeutic approaches. By addressing specific unmet medical needs and exploring underdeveloped areas, these smaller players aim to differentiate themselves and capture new growth opportunities, ultimately contributing to the overall advancement and diversification of the market.

Key Players

• Haleon plc

• GSK plc

• Merck & Co., Inc.

• Himalaya Wellness Company

• Jadran-galenski laboratorij d.d. JGL d.d.

• NeilMed Pharmaceuticals, Inc.

• Aurena Laboratories AB

• Church & Dwight Co., Inc.

• Xlear, Inc.

• Sandoz International GmbH

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The anti-pollution nasal spray market is expected to witness steady growth as global air pollution continues to rise, driving consumers to seek effective respiratory protection solutions. Increasing awareness of nasal health, expanding product innovation, and growing availability through retail and online channels further support market expansion. Companies are focusing on advanced formulations and broader distribution to meet rising demand, especially in urban regions with higher pollution exposure. With pollution-related health concerns becoming more prominent and preventive healthcare gaining importance, the market is likely to maintain strong momentum in the coming years.